ImmPACT Bio

ImmPACT Bio is dedicated to the discovery and advancement of transformative therapies, now as part of Lyell Immunopharma. Specializing in cutting-edge chimeric antigen receptor (CAR) T-cell therapies, ImmPACT Bio focuses on addressing critical biological challenges in treating cancer and autoimmune diseases. The company's innovative approach aims to precisely distinguish cancer and diseased cells from normal cells, eliminating them without harming normal tissues. ImmPACT Bio's primary address is located at 8501 Fallbrook Ave, 200, West Hills, California 91304, US, with an additional location at 2 E.D.Bergman St., Rehovot, IL.

With a strong foundation in biotechnology research, ImmPACT Bio is committed to pioneering selective treatments and advancing the field of immunotherapy. The company's work in on-target, off-tumor toxicity and logic gate technologies underscores its dedication to developing advanced solutions for patients with unmet needs. ImmPACT Bio continues to innovate and expand its capabilities in cancer therapy and oncology.

ImmPACT Bio is focused on developing next-generation cell therapies that offer patients improved outcomes, with our Corporate offices in West Hills, CA, featuring a state-of-the-art clinical manufacturing facility. To learn more about customized solutions and potential collaborations, management is invited to create a customized and exclusive company showcase and product listing on our platform.